Zobrazeno 1 - 10
of 101
pro vyhledávání: '"H. Bontemps"'
Autor:
Willem S. Lexmond, Vincent E. de Meijer, René Scheenstra, Sander T. H. Bontemps, Evelien W. Duiker, Elisabeth H. Schölvinck, Xuewei Zhou, Karin J. von Eije, Koen M. E. M. Reyntjens, Henkjan J. Verkade, Robert J. Porte, Ruben H. de Kleine
Publikováno v:
United European Gastroenterology Journal, 10(8). SAGE Publications Inc.
There is increasing global concern of severe acute hepatitis of unknown etiology in young children. In early 2022, our center for liver transplantation in the Netherlands treated five children who presented in short succession with indeterminate acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7143b9f9515623b0a95fe7908be81c20
https://research.rug.nl/en/publications/4bc57e5b-1be9-4a8d-bac0-661a7b9c5b33
https://research.rug.nl/en/publications/4bc57e5b-1be9-4a8d-bac0-661a7b9c5b33
Autor:
J. Coutet, M. Bourdelin, E. Jean-Bart, Emmanuelle Pont, Jean-Baptiste Pace, H. Bontemps, Camille Petit
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:460-462
Publikováno v:
Le Pharmacien Clinicien. 57:e95-e96
Autor:
Noémi Ricard, H. Bontemps, Michel Mallaret, Dominique Arpin, Claire Marine Gaillard, Sandra Coursier
Publikováno v:
La Presse Médicale Formation. 2:551-553
Autor:
Ton Lisman, Vincent E de Meijer, Robert J. Porte, Jelle Adelmeijer, Sander T H Bontemps, Maureen J M Werner, Jan B F Hulscher, Ruben H J de Kleine, Koen Reyntjens, Rene Scheenstra
Publikováno v:
Thrombosis and Haemostasis, 120(09), 1240-1247. GEORG THIEME VERLAG KG
Background Pro- and anticoagulant drugs are commonly used in pediatric liver transplantation to prevent and treat thrombotic and bleeding complications. However, the combination of baseline hemostatic changes in children with liver disease and additi
Autor:
Ton Lisman, Riksta Dikkers, Marieke T. de Boer, Sander T H Bontemps, Maureen J M Werner, Koen Reyntjens, Robert J. Porte, Frank A J A Bodewes, Rene Scheenstra, Henkjan J. Verkade, Ruben H J de Kleine, Vincent E de Meijer
Publikováno v:
Thrombosis and Haemostasis, 120(4), 627-637. GEORG THIEME VERLAG KG
Thrombosis and haemostasis, 120(4), 627-637. Schattauer GmbH
Thrombosis and haemostasis, 120(4), 627-637. Schattauer GmbH
Background Hepatic artery thrombosis (HAT) and portal vein thrombosis (PVT) are serious causes of morbidity and mortality after pediatric liver transplantation. To reduce thrombotic complications, routine antithrombotic therapy consisting of 1 week h
Autor:
Koen Reyntjens, Vincent E de Meijer, Rene Scheenstra, Sander T H Bontemps, Ton Lisman, Robert J. Porte, Jan B F Hulscher, Jelle Adelmeijer, Ruben H J de Kleine, Maureen J M Werner
Publikováno v:
American Journal of Transplantation
American Journal of Transplantation, 20(5), 1384-1392. Wiley
American Journal of Transplantation, 20(5), 1384-1392. Wiley
In adults with end‐stage liver disease concurrent changes in pro‐ and antihemostatic pathways result in a rebalanced hemostasis. Children though, have a developing hemostatic system, different disease etiologies, and increased risk of thrombosis.
Autor:
E. Jean-Bart, B. Falquet, E. Cartet, Jean-Baptiste Pace, C. Petit, M. Bourdelin, J. Coutet, B. Leroy, Emmanuelle Pont, H. Bontemps, F. Foltz, C. Renzullo
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 55:87-89
Autor:
J. Coutet, Jean-Louis Bonnefous, H. Bontemps, M. Bourdelin, Carine Eyssette, Mélanie Moulis, E. Jean-Bart, Viviane Nave, Bertrand Leroy, Sandra Coursier, Emmanuelle Pont, Jean-Baptiste Pace
Publikováno v:
Therapies. 72:579-586
Resume Objectif Le paracetamol est largement utilise a l’hopital et souvent considere a tort comme non toxique. Nous avons mene une etude multicentrique pour evaluer son bon usage. Methode Les adaptations posologiques en fonction de l’atteinte re
Autor:
B. Leroy, J. Coutet, M. Bourdelin, C. Renzullo, S. Coursier, H. Bontemps, Michaël Philippe, E. Jean-Bart
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 52:229-236
Resume Introduction L’identification des patients, des prescriptions et situations a risque iatrogene est un enjeu majeur de l’optimisation de la prise en charge medicamenteuse et de la lutte contre l’iatrogenie. L’objectif de cette etude est